Health Care [ 3/12 ] | Biotechnology [ 22/74 ]
NASDAQ | Common Stock
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure.
Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 1, 26 | -0.05 Increased by +48.40% | -0.08 Increased by +37.53% |
| Dec 31, 25 | -0.07 Increased by +22.22% | -0.11 Increased by +36.36% |
| Nov 18, 25 | -0.09 Increased by +52.39% | -0.08 Decreased by -10.58% |
| Aug 19, 25 | -0.07 Increased by +27.80% | -0.10 Increased by +27.58% |
| May 12, 25 | -0.10 Increased by +16.67% | -0.08 Decreased by -25.00% |
| Mar 31, 25 | -0.09 Increased by 0.00% | -0.12 Increased by +22.88% |
| Nov 12, 24 | -0.18 Decreased by -100.00% | -0.08 Decreased by -125.00% |
| Aug 12, 24 | -0.10 Increased by +16.67% | -0.13 Increased by +23.08% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by N/A% | -10.85 M Decreased by -30.88% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -7.21 M Decreased by -26.91% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -9.96 M Increased by +21.72% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -8.35 M Decreased by -73.47% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -8.29 M Increased by +9.72% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -5.68 M Increased by +25.58% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -12.73 M Decreased by -191.59% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -4.82 M Increased by +14.56% | Decreased by N/A% Decreased by N/A% |